Global RNA-Based Therapeutics and Vaccines Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global RNA-Based Therapeutics and Vaccines market size was valued at US$ 25 million in 2023. With growing demand in downstream market, the RNA-Based Therapeutics and Vaccines is forecast to a readjusted size of US$ 652.2 million by 2030 with a CAGR of 59.5% during review period.
The research report highlights the growth potential of the global RNA-Based Therapeutics and Vaccines market. RNA-Based Therapeutics and Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of RNA-Based Therapeutics and Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the RNA-Based Therapeutics and Vaccines market.
RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on RNA-Based Therapeutics and Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the RNA-Based Therapeutics and Vaccines market. It may include historical data, market segmentation by Type (e.g., RNA-Based Therapeutics, RNA-Based Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the RNA-Based Therapeutics and Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the RNA-Based Therapeutics and Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the RNA-Based Therapeutics and Vaccines industry. This include advancements in RNA-Based Therapeutics and Vaccines technology, RNA-Based Therapeutics and Vaccines new entrants, RNA-Based Therapeutics and Vaccines new investment, and other innovations that are shaping the future of RNA-Based Therapeutics and Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the RNA-Based Therapeutics and Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for RNA-Based Therapeutics and Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the RNA-Based Therapeutics and Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting RNA-Based Therapeutics and Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the RNA-Based Therapeutics and Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the RNA-Based Therapeutics and Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the RNA-Based Therapeutics and Vaccines market.
Market Segmentation:
RNA-Based Therapeutics and Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global RNA-Based Therapeutics and Vaccines market size was valued at US$ 25 million in 2023. With growing demand in downstream market, the RNA-Based Therapeutics and Vaccines is forecast to a readjusted size of US$ 652.2 million by 2030 with a CAGR of 59.5% during review period.
The research report highlights the growth potential of the global RNA-Based Therapeutics and Vaccines market. RNA-Based Therapeutics and Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of RNA-Based Therapeutics and Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the RNA-Based Therapeutics and Vaccines market.
RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on RNA-Based Therapeutics and Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the RNA-Based Therapeutics and Vaccines market. It may include historical data, market segmentation by Type (e.g., RNA-Based Therapeutics, RNA-Based Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the RNA-Based Therapeutics and Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the RNA-Based Therapeutics and Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the RNA-Based Therapeutics and Vaccines industry. This include advancements in RNA-Based Therapeutics and Vaccines technology, RNA-Based Therapeutics and Vaccines new entrants, RNA-Based Therapeutics and Vaccines new investment, and other innovations that are shaping the future of RNA-Based Therapeutics and Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the RNA-Based Therapeutics and Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for RNA-Based Therapeutics and Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the RNA-Based Therapeutics and Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting RNA-Based Therapeutics and Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the RNA-Based Therapeutics and Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the RNA-Based Therapeutics and Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the RNA-Based Therapeutics and Vaccines market.
Market Segmentation:
RNA-Based Therapeutics and Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- RNA-Based Therapeutics
- RNA-Based Vaccines
- Oncology
- Immunology
- Ophthalmology
- Cardiovascular Diseases
- Infectious Diseases
- Genetic Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Alnylam Pharmaceuticals
- Arbutus Biopharma
- Arrowhead Pharmaceuticals
- BioNTech
- CureVac
- Dicerna Pharmaceuticals
- Regulus Therapeutics
- Marina Biotech
- MiRagen Therapeutics
- Moderna Therapeutics
- Quark Pharmaceuticals
- Roche
- Sylentis
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global RNA-Based Therapeutics and Vaccines Market Size 2019-2030
2.1.2 RNA-Based Therapeutics and Vaccines Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 RNA-Based Therapeutics and Vaccines Segment by Type
2.2.1 RNA-Based Therapeutics
2.2.2 RNA-Based Vaccines
2.3 RNA-Based Therapeutics and Vaccines Market Size by Type
2.3.1 RNA-Based Therapeutics and Vaccines Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
2.4 RNA-Based Therapeutics and Vaccines Segment by Application
2.4.1 Oncology
2.4.2 Immunology
2.4.3 Ophthalmology
2.4.4 Cardiovascular Diseases
2.4.5 Infectious Diseases
2.4.6 Genetic Diseases
2.4.7 Others
2.5 RNA-Based Therapeutics and Vaccines Market Size by Application
2.5.1 RNA-Based Therapeutics and Vaccines Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
3 RNA-BASED THERAPEUTICS AND VACCINES MARKET SIZE BY PLAYER
3.1 RNA-Based Therapeutics and Vaccines Market Size Market Share by Players
3.1.1 Global RNA-Based Therapeutics and Vaccines Revenue by Players (2019-2024)
3.1.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Players (2019-2024)
3.2 Global RNA-Based Therapeutics and Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RNA-BASED THERAPEUTICS AND VACCINES BY REGIONS
4.1 RNA-Based Therapeutics and Vaccines Market Size by Regions (2019-2024)
4.2 Americas RNA-Based Therapeutics and Vaccines Market Size Growth (2019-2024)
4.3 APAC RNA-Based Therapeutics and Vaccines Market Size Growth (2019-2024)
4.4 Europe RNA-Based Therapeutics and Vaccines Market Size Growth (2019-2024)
4.5 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas RNA-Based Therapeutics and Vaccines Market Size by Country (2019-2024)
5.2 Americas RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024)
5.3 Americas RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA-Based Therapeutics and Vaccines Market Size by Region (2019-2024)
6.2 APAC RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024)
6.3 APAC RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe RNA-Based Therapeutics and Vaccines by Country (2019-2024)
7.2 Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024)
7.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa RNA-Based Therapeutics and Vaccines by Region (2019-2024)
8.2 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024)
8.3 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET FORECAST
10.1 Global RNA-Based Therapeutics and Vaccines Forecast by Regions (2025-2030)
10.1.1 Global RNA-Based Therapeutics and Vaccines Forecast by Regions (2025-2030)
10.1.2 Americas RNA-Based Therapeutics and Vaccines Forecast
10.1.3 APAC RNA-Based Therapeutics and Vaccines Forecast
10.1.4 Europe RNA-Based Therapeutics and Vaccines Forecast
10.1.5 Middle East & Africa RNA-Based Therapeutics and Vaccines Forecast
10.2 Americas RNA-Based Therapeutics and Vaccines Forecast by Country (2025-2030)
10.2.1 United States RNA-Based Therapeutics and Vaccines Market Forecast
10.2.2 Canada RNA-Based Therapeutics and Vaccines Market Forecast
10.2.3 Mexico RNA-Based Therapeutics and Vaccines Market Forecast
10.2.4 Brazil RNA-Based Therapeutics and Vaccines Market Forecast
10.3 APAC RNA-Based Therapeutics and Vaccines Forecast by Region (2025-2030)
10.3.1 China RNA-Based Therapeutics and Vaccines Market Forecast
10.3.2 Japan RNA-Based Therapeutics and Vaccines Market Forecast
10.3.3 Korea RNA-Based Therapeutics and Vaccines Market Forecast
10.3.4 Southeast Asia RNA-Based Therapeutics and Vaccines Market Forecast
10.3.5 India RNA-Based Therapeutics and Vaccines Market Forecast
10.3.6 Australia RNA-Based Therapeutics and Vaccines Market Forecast
10.4 Europe RNA-Based Therapeutics and Vaccines Forecast by Country (2025-2030)
10.4.1 Germany RNA-Based Therapeutics and Vaccines Market Forecast
10.4.2 France RNA-Based Therapeutics and Vaccines Market Forecast
10.4.3 UK RNA-Based Therapeutics and Vaccines Market Forecast
10.4.4 Italy RNA-Based Therapeutics and Vaccines Market Forecast
10.4.5 Russia RNA-Based Therapeutics and Vaccines Market Forecast
10.5 Middle East & Africa RNA-Based Therapeutics and Vaccines Forecast by Region (2025-2030)
10.5.1 Egypt RNA-Based Therapeutics and Vaccines Market Forecast
10.5.2 South Africa RNA-Based Therapeutics and Vaccines Market Forecast
10.5.3 Israel RNA-Based Therapeutics and Vaccines Market Forecast
10.5.4 Turkey RNA-Based Therapeutics and Vaccines Market Forecast
10.5.5 GCC Countries RNA-Based Therapeutics and Vaccines Market Forecast
10.6 Global RNA-Based Therapeutics and Vaccines Forecast by Type (2025-2030)
10.7 Global RNA-Based Therapeutics and Vaccines Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Information
11.1.2 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
11.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Alnylam Pharmaceuticals Main Business Overview
11.1.5 Alnylam Pharmaceuticals Latest Developments
11.2 Arbutus Biopharma
11.2.1 Arbutus Biopharma Company Information
11.2.2 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product Offered
11.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Arbutus Biopharma Main Business Overview
11.2.5 Arbutus Biopharma Latest Developments
11.3 Arrowhead Pharmaceuticals
11.3.1 Arrowhead Pharmaceuticals Company Information
11.3.2 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
11.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Arrowhead Pharmaceuticals Main Business Overview
11.3.5 Arrowhead Pharmaceuticals Latest Developments
11.4 BioNTech
11.4.1 BioNTech Company Information
11.4.2 BioNTech RNA-Based Therapeutics and Vaccines Product Offered
11.4.3 BioNTech RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 BioNTech Main Business Overview
11.4.5 BioNTech Latest Developments
11.5 CureVac
11.5.1 CureVac Company Information
11.5.2 CureVac RNA-Based Therapeutics and Vaccines Product Offered
11.5.3 CureVac RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 CureVac Main Business Overview
11.5.5 CureVac Latest Developments
11.6 Dicerna Pharmaceuticals
11.6.1 Dicerna Pharmaceuticals Company Information
11.6.2 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
11.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Dicerna Pharmaceuticals Main Business Overview
11.6.5 Dicerna Pharmaceuticals Latest Developments
11.7 Regulus Therapeutics
11.7.1 Regulus Therapeutics Company Information
11.7.2 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
11.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Regulus Therapeutics Main Business Overview
11.7.5 Regulus Therapeutics Latest Developments
11.8 Marina Biotech
11.8.1 Marina Biotech Company Information
11.8.2 Marina Biotech RNA-Based Therapeutics and Vaccines Product Offered
11.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Marina Biotech Main Business Overview
11.8.5 Marina Biotech Latest Developments
11.9 MiRagen Therapeutics
11.9.1 MiRagen Therapeutics Company Information
11.9.2 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
11.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 MiRagen Therapeutics Main Business Overview
11.9.5 MiRagen Therapeutics Latest Developments
11.10 Moderna Therapeutics
11.10.1 Moderna Therapeutics Company Information
11.10.2 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
11.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Moderna Therapeutics Main Business Overview
11.10.5 Moderna Therapeutics Latest Developments
11.11 Quark Pharmaceuticals
11.11.1 Quark Pharmaceuticals Company Information
11.11.2 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
11.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Quark Pharmaceuticals Main Business Overview
11.11.5 Quark Pharmaceuticals Latest Developments
11.12 Roche
11.12.1 Roche Company Information
11.12.2 Roche RNA-Based Therapeutics and Vaccines Product Offered
11.12.3 Roche RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Roche Main Business Overview
11.12.5 Roche Latest Developments
11.13 Sylentis
11.13.1 Sylentis Company Information
11.13.2 Sylentis RNA-Based Therapeutics and Vaccines Product Offered
11.13.3 Sylentis RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Sylentis Main Business Overview
11.13.5 Sylentis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global RNA-Based Therapeutics and Vaccines Market Size 2019-2030
2.1.2 RNA-Based Therapeutics and Vaccines Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 RNA-Based Therapeutics and Vaccines Segment by Type
2.2.1 RNA-Based Therapeutics
2.2.2 RNA-Based Vaccines
2.3 RNA-Based Therapeutics and Vaccines Market Size by Type
2.3.1 RNA-Based Therapeutics and Vaccines Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
2.4 RNA-Based Therapeutics and Vaccines Segment by Application
2.4.1 Oncology
2.4.2 Immunology
2.4.3 Ophthalmology
2.4.4 Cardiovascular Diseases
2.4.5 Infectious Diseases
2.4.6 Genetic Diseases
2.4.7 Others
2.5 RNA-Based Therapeutics and Vaccines Market Size by Application
2.5.1 RNA-Based Therapeutics and Vaccines Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
3 RNA-BASED THERAPEUTICS AND VACCINES MARKET SIZE BY PLAYER
3.1 RNA-Based Therapeutics and Vaccines Market Size Market Share by Players
3.1.1 Global RNA-Based Therapeutics and Vaccines Revenue by Players (2019-2024)
3.1.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Players (2019-2024)
3.2 Global RNA-Based Therapeutics and Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RNA-BASED THERAPEUTICS AND VACCINES BY REGIONS
4.1 RNA-Based Therapeutics and Vaccines Market Size by Regions (2019-2024)
4.2 Americas RNA-Based Therapeutics and Vaccines Market Size Growth (2019-2024)
4.3 APAC RNA-Based Therapeutics and Vaccines Market Size Growth (2019-2024)
4.4 Europe RNA-Based Therapeutics and Vaccines Market Size Growth (2019-2024)
4.5 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas RNA-Based Therapeutics and Vaccines Market Size by Country (2019-2024)
5.2 Americas RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024)
5.3 Americas RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA-Based Therapeutics and Vaccines Market Size by Region (2019-2024)
6.2 APAC RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024)
6.3 APAC RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe RNA-Based Therapeutics and Vaccines by Country (2019-2024)
7.2 Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024)
7.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa RNA-Based Therapeutics and Vaccines by Region (2019-2024)
8.2 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024)
8.3 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET FORECAST
10.1 Global RNA-Based Therapeutics and Vaccines Forecast by Regions (2025-2030)
10.1.1 Global RNA-Based Therapeutics and Vaccines Forecast by Regions (2025-2030)
10.1.2 Americas RNA-Based Therapeutics and Vaccines Forecast
10.1.3 APAC RNA-Based Therapeutics and Vaccines Forecast
10.1.4 Europe RNA-Based Therapeutics and Vaccines Forecast
10.1.5 Middle East & Africa RNA-Based Therapeutics and Vaccines Forecast
10.2 Americas RNA-Based Therapeutics and Vaccines Forecast by Country (2025-2030)
10.2.1 United States RNA-Based Therapeutics and Vaccines Market Forecast
10.2.2 Canada RNA-Based Therapeutics and Vaccines Market Forecast
10.2.3 Mexico RNA-Based Therapeutics and Vaccines Market Forecast
10.2.4 Brazil RNA-Based Therapeutics and Vaccines Market Forecast
10.3 APAC RNA-Based Therapeutics and Vaccines Forecast by Region (2025-2030)
10.3.1 China RNA-Based Therapeutics and Vaccines Market Forecast
10.3.2 Japan RNA-Based Therapeutics and Vaccines Market Forecast
10.3.3 Korea RNA-Based Therapeutics and Vaccines Market Forecast
10.3.4 Southeast Asia RNA-Based Therapeutics and Vaccines Market Forecast
10.3.5 India RNA-Based Therapeutics and Vaccines Market Forecast
10.3.6 Australia RNA-Based Therapeutics and Vaccines Market Forecast
10.4 Europe RNA-Based Therapeutics and Vaccines Forecast by Country (2025-2030)
10.4.1 Germany RNA-Based Therapeutics and Vaccines Market Forecast
10.4.2 France RNA-Based Therapeutics and Vaccines Market Forecast
10.4.3 UK RNA-Based Therapeutics and Vaccines Market Forecast
10.4.4 Italy RNA-Based Therapeutics and Vaccines Market Forecast
10.4.5 Russia RNA-Based Therapeutics and Vaccines Market Forecast
10.5 Middle East & Africa RNA-Based Therapeutics and Vaccines Forecast by Region (2025-2030)
10.5.1 Egypt RNA-Based Therapeutics and Vaccines Market Forecast
10.5.2 South Africa RNA-Based Therapeutics and Vaccines Market Forecast
10.5.3 Israel RNA-Based Therapeutics and Vaccines Market Forecast
10.5.4 Turkey RNA-Based Therapeutics and Vaccines Market Forecast
10.5.5 GCC Countries RNA-Based Therapeutics and Vaccines Market Forecast
10.6 Global RNA-Based Therapeutics and Vaccines Forecast by Type (2025-2030)
10.7 Global RNA-Based Therapeutics and Vaccines Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Information
11.1.2 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
11.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Alnylam Pharmaceuticals Main Business Overview
11.1.5 Alnylam Pharmaceuticals Latest Developments
11.2 Arbutus Biopharma
11.2.1 Arbutus Biopharma Company Information
11.2.2 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product Offered
11.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Arbutus Biopharma Main Business Overview
11.2.5 Arbutus Biopharma Latest Developments
11.3 Arrowhead Pharmaceuticals
11.3.1 Arrowhead Pharmaceuticals Company Information
11.3.2 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
11.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Arrowhead Pharmaceuticals Main Business Overview
11.3.5 Arrowhead Pharmaceuticals Latest Developments
11.4 BioNTech
11.4.1 BioNTech Company Information
11.4.2 BioNTech RNA-Based Therapeutics and Vaccines Product Offered
11.4.3 BioNTech RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 BioNTech Main Business Overview
11.4.5 BioNTech Latest Developments
11.5 CureVac
11.5.1 CureVac Company Information
11.5.2 CureVac RNA-Based Therapeutics and Vaccines Product Offered
11.5.3 CureVac RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 CureVac Main Business Overview
11.5.5 CureVac Latest Developments
11.6 Dicerna Pharmaceuticals
11.6.1 Dicerna Pharmaceuticals Company Information
11.6.2 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
11.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Dicerna Pharmaceuticals Main Business Overview
11.6.5 Dicerna Pharmaceuticals Latest Developments
11.7 Regulus Therapeutics
11.7.1 Regulus Therapeutics Company Information
11.7.2 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
11.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Regulus Therapeutics Main Business Overview
11.7.5 Regulus Therapeutics Latest Developments
11.8 Marina Biotech
11.8.1 Marina Biotech Company Information
11.8.2 Marina Biotech RNA-Based Therapeutics and Vaccines Product Offered
11.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Marina Biotech Main Business Overview
11.8.5 Marina Biotech Latest Developments
11.9 MiRagen Therapeutics
11.9.1 MiRagen Therapeutics Company Information
11.9.2 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
11.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 MiRagen Therapeutics Main Business Overview
11.9.5 MiRagen Therapeutics Latest Developments
11.10 Moderna Therapeutics
11.10.1 Moderna Therapeutics Company Information
11.10.2 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
11.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Moderna Therapeutics Main Business Overview
11.10.5 Moderna Therapeutics Latest Developments
11.11 Quark Pharmaceuticals
11.11.1 Quark Pharmaceuticals Company Information
11.11.2 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
11.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Quark Pharmaceuticals Main Business Overview
11.11.5 Quark Pharmaceuticals Latest Developments
11.12 Roche
11.12.1 Roche Company Information
11.12.2 Roche RNA-Based Therapeutics and Vaccines Product Offered
11.12.3 Roche RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Roche Main Business Overview
11.12.5 Roche Latest Developments
11.13 Sylentis
11.13.1 Sylentis Company Information
11.13.2 Sylentis RNA-Based Therapeutics and Vaccines Product Offered
11.13.3 Sylentis RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Sylentis Main Business Overview
11.13.5 Sylentis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. RNA-Based Therapeutics and Vaccines Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of RNA-Based Therapeutics
Table 3. Major Players of RNA-Based Vaccines
Table 4. RNA-Based Therapeutics and Vaccines Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
Table 7. RNA-Based Therapeutics and Vaccines Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
Table 10. Global RNA-Based Therapeutics and Vaccines Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Player (2019-2024)
Table 12. RNA-Based Therapeutics and Vaccines Key Players Head office and Products Offered
Table 13. RNA-Based Therapeutics and Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global RNA-Based Therapeutics and Vaccines Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Regions (2019-2024)
Table 18. Global RNA-Based Therapeutics and Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas RNA-Based Therapeutics and Vaccines Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Country (2019-2024)
Table 22. Americas RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
Table 24. Americas RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
Table 26. APAC RNA-Based Therapeutics and Vaccines Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Region (2019-2024)
Table 28. APAC RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
Table 30. APAC RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
Table 32. Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Country (2019-2024)
Table 34. Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
Table 36. Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of RNA-Based Therapeutics and Vaccines
Table 45. Key Market Challenges & Risks of RNA-Based Therapeutics and Vaccines
Table 46. Key Industry Trends of RNA-Based Therapeutics and Vaccines
Table 47. Global RNA-Based Therapeutics and Vaccines Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global RNA-Based Therapeutics and Vaccines Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global RNA-Based Therapeutics and Vaccines Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global RNA-Based Therapeutics and Vaccines Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Alnylam Pharmaceuticals Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 52. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
Table 53. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Alnylam Pharmaceuticals Main Business
Table 55. Alnylam Pharmaceuticals Latest Developments
Table 56. Arbutus Biopharma Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 57. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product Offered
Table 58. Arbutus Biopharma Main Business
Table 59. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Arbutus Biopharma Latest Developments
Table 61. Arrowhead Pharmaceuticals Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 62. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
Table 63. Arrowhead Pharmaceuticals Main Business
Table 64. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Arrowhead Pharmaceuticals Latest Developments
Table 66. BioNTech Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 67. BioNTech RNA-Based Therapeutics and Vaccines Product Offered
Table 68. BioNTech Main Business
Table 69. BioNTech RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. BioNTech Latest Developments
Table 71. CureVac Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 72. CureVac RNA-Based Therapeutics and Vaccines Product Offered
Table 73. CureVac Main Business
Table 74. CureVac RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. CureVac Latest Developments
Table 76. Dicerna Pharmaceuticals Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 77. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
Table 78. Dicerna Pharmaceuticals Main Business
Table 79. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Dicerna Pharmaceuticals Latest Developments
Table 81. Regulus Therapeutics Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 82. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
Table 83. Regulus Therapeutics Main Business
Table 84. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Regulus Therapeutics Latest Developments
Table 86. Marina Biotech Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 87. Marina Biotech RNA-Based Therapeutics and Vaccines Product Offered
Table 88. Marina Biotech Main Business
Table 89. Marina Biotech RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Marina Biotech Latest Developments
Table 91. MiRagen Therapeutics Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 92. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
Table 93. MiRagen Therapeutics Main Business
Table 94. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. MiRagen Therapeutics Latest Developments
Table 96. Moderna Therapeutics Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 97. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
Table 98. Moderna Therapeutics Main Business
Table 99. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Moderna Therapeutics Latest Developments
Table 101. Quark Pharmaceuticals Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 102. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
Table 103. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Quark Pharmaceuticals Main Business
Table 105. Quark Pharmaceuticals Latest Developments
Table 106. Roche Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 107. Roche RNA-Based Therapeutics and Vaccines Product Offered
Table 108. Roche Main Business
Table 109. Roche RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Roche Latest Developments
Table 111. Sylentis Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 112. Sylentis RNA-Based Therapeutics and Vaccines Product Offered
Table 113. Sylentis Main Business
Table 114. Sylentis RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Sylentis Latest Developments
Table 1. RNA-Based Therapeutics and Vaccines Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of RNA-Based Therapeutics
Table 3. Major Players of RNA-Based Vaccines
Table 4. RNA-Based Therapeutics and Vaccines Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
Table 7. RNA-Based Therapeutics and Vaccines Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
Table 10. Global RNA-Based Therapeutics and Vaccines Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Player (2019-2024)
Table 12. RNA-Based Therapeutics and Vaccines Key Players Head office and Products Offered
Table 13. RNA-Based Therapeutics and Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global RNA-Based Therapeutics and Vaccines Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Regions (2019-2024)
Table 18. Global RNA-Based Therapeutics and Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas RNA-Based Therapeutics and Vaccines Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Country (2019-2024)
Table 22. Americas RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
Table 24. Americas RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
Table 26. APAC RNA-Based Therapeutics and Vaccines Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Region (2019-2024)
Table 28. APAC RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
Table 30. APAC RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
Table 32. Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Country (2019-2024)
Table 34. Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
Table 36. Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of RNA-Based Therapeutics and Vaccines
Table 45. Key Market Challenges & Risks of RNA-Based Therapeutics and Vaccines
Table 46. Key Industry Trends of RNA-Based Therapeutics and Vaccines
Table 47. Global RNA-Based Therapeutics and Vaccines Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global RNA-Based Therapeutics and Vaccines Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global RNA-Based Therapeutics and Vaccines Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global RNA-Based Therapeutics and Vaccines Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Alnylam Pharmaceuticals Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 52. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
Table 53. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Alnylam Pharmaceuticals Main Business
Table 55. Alnylam Pharmaceuticals Latest Developments
Table 56. Arbutus Biopharma Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 57. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product Offered
Table 58. Arbutus Biopharma Main Business
Table 59. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Arbutus Biopharma Latest Developments
Table 61. Arrowhead Pharmaceuticals Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 62. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
Table 63. Arrowhead Pharmaceuticals Main Business
Table 64. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Arrowhead Pharmaceuticals Latest Developments
Table 66. BioNTech Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 67. BioNTech RNA-Based Therapeutics and Vaccines Product Offered
Table 68. BioNTech Main Business
Table 69. BioNTech RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. BioNTech Latest Developments
Table 71. CureVac Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 72. CureVac RNA-Based Therapeutics and Vaccines Product Offered
Table 73. CureVac Main Business
Table 74. CureVac RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. CureVac Latest Developments
Table 76. Dicerna Pharmaceuticals Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 77. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
Table 78. Dicerna Pharmaceuticals Main Business
Table 79. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Dicerna Pharmaceuticals Latest Developments
Table 81. Regulus Therapeutics Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 82. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
Table 83. Regulus Therapeutics Main Business
Table 84. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Regulus Therapeutics Latest Developments
Table 86. Marina Biotech Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 87. Marina Biotech RNA-Based Therapeutics and Vaccines Product Offered
Table 88. Marina Biotech Main Business
Table 89. Marina Biotech RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Marina Biotech Latest Developments
Table 91. MiRagen Therapeutics Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 92. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
Table 93. MiRagen Therapeutics Main Business
Table 94. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. MiRagen Therapeutics Latest Developments
Table 96. Moderna Therapeutics Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 97. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product Offered
Table 98. Moderna Therapeutics Main Business
Table 99. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Moderna Therapeutics Latest Developments
Table 101. Quark Pharmaceuticals Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 102. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offered
Table 103. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Quark Pharmaceuticals Main Business
Table 105. Quark Pharmaceuticals Latest Developments
Table 106. Roche Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 107. Roche RNA-Based Therapeutics and Vaccines Product Offered
Table 108. Roche Main Business
Table 109. Roche RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Roche Latest Developments
Table 111. Sylentis Details, Company Type, RNA-Based Therapeutics and Vaccines Area Served and Its Competitors
Table 112. Sylentis RNA-Based Therapeutics and Vaccines Product Offered
Table 113. Sylentis Main Business
Table 114. Sylentis RNA-Based Therapeutics and Vaccines Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Sylentis Latest Developments
LIST OF FIGURES
Figure 1. RNA-Based Therapeutics and Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. RNA-Based Therapeutics and Vaccines Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. RNA-Based Therapeutics and Vaccines Sales Market Share by Country/Region (2023)
Figure 8. RNA-Based Therapeutics and Vaccines Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type in 2023
Figure 10. RNA-Based Therapeutics and Vaccines in Oncology
Figure 11. Global RNA-Based Therapeutics and Vaccines Market: Oncology (2019-2024) & ($ Millions)
Figure 12. RNA-Based Therapeutics and Vaccines in Immunology
Figure 13. Global RNA-Based Therapeutics and Vaccines Market: Immunology (2019-2024) & ($ Millions)
Figure 14. RNA-Based Therapeutics and Vaccines in Ophthalmology
Figure 15. Global RNA-Based Therapeutics and Vaccines Market: Ophthalmology (2019-2024) & ($ Millions)
Figure 16. RNA-Based Therapeutics and Vaccines in Cardiovascular Diseases
Figure 17. Global RNA-Based Therapeutics and Vaccines Market: Cardiovascular Diseases (2019-2024) & ($ Millions)
Figure 18. RNA-Based Therapeutics and Vaccines in Infectious Diseases
Figure 19. Global RNA-Based Therapeutics and Vaccines Market: Infectious Diseases (2019-2024) & ($ Millions)
Figure 20. RNA-Based Therapeutics and Vaccines in Genetic Diseases
Figure 21. Global RNA-Based Therapeutics and Vaccines Market: Genetic Diseases (2019-2024) & ($ Millions)
Figure 22. RNA-Based Therapeutics and Vaccines in Others
Figure 23. Global RNA-Based Therapeutics and Vaccines Market: Others (2019-2024) & ($ Millions)
Figure 24. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Application in 2023
Figure 25. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Player in 2023
Figure 26. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Regions (2019-2024)
Figure 27. Americas RNA-Based Therapeutics and Vaccines Market Size 2019-2024 ($ Millions)
Figure 28. APAC RNA-Based Therapeutics and Vaccines Market Size 2019-2024 ($ Millions)
Figure 29. Europe RNA-Based Therapeutics and Vaccines Market Size 2019-2024 ($ Millions)
Figure 30. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size 2019-2024 ($ Millions)
Figure 31. Americas RNA-Based Therapeutics and Vaccines Value Market Share by Country in 2023
Figure 32. United States RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 33. Canada RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 34. Mexico RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 35. Brazil RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 36. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Region in 2023
Figure 37. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Type in 2023
Figure 38. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Application in 2023
Figure 39. China RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 40. Japan RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 41. Korea RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 42. Southeast Asia RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 43. India RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 44. Australia RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 45. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Country in 2023
Figure 46. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
Figure 47. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
Figure 48. Germany RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 49. France RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 50. UK RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 51. Italy RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 52. Russia RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 53. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Region (2019-2024)
Figure 54. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
Figure 55. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
Figure 56. Egypt RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 57. South Africa RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 58. Israel RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 59. Turkey RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 60. GCC Country RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 61. Americas RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 62. APAC RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 63. Europe RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 64. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 65. United States RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 66. Canada RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 67. Mexico RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 68. Brazil RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 69. China RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 70. Japan RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 71. Korea RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 72. Southeast Asia RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 73. India RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 74. Australia RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 75. Germany RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 76. France RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 77. UK RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 78. Italy RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 79. Russia RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 80. Spain RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 81. Egypt RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 82. South Africa RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 83. Israel RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 84. Turkey RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 85. GCC Countries RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 86. Global RNA-Based Therapeutics and Vaccines Market Size Market Share Forecast by Type (2025-2030)
Figure 87. Global RNA-Based Therapeutics and Vaccines Market Size Market Share Forecast by Application (2025-2030)
Figure 1. RNA-Based Therapeutics and Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. RNA-Based Therapeutics and Vaccines Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. RNA-Based Therapeutics and Vaccines Sales Market Share by Country/Region (2023)
Figure 8. RNA-Based Therapeutics and Vaccines Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type in 2023
Figure 10. RNA-Based Therapeutics and Vaccines in Oncology
Figure 11. Global RNA-Based Therapeutics and Vaccines Market: Oncology (2019-2024) & ($ Millions)
Figure 12. RNA-Based Therapeutics and Vaccines in Immunology
Figure 13. Global RNA-Based Therapeutics and Vaccines Market: Immunology (2019-2024) & ($ Millions)
Figure 14. RNA-Based Therapeutics and Vaccines in Ophthalmology
Figure 15. Global RNA-Based Therapeutics and Vaccines Market: Ophthalmology (2019-2024) & ($ Millions)
Figure 16. RNA-Based Therapeutics and Vaccines in Cardiovascular Diseases
Figure 17. Global RNA-Based Therapeutics and Vaccines Market: Cardiovascular Diseases (2019-2024) & ($ Millions)
Figure 18. RNA-Based Therapeutics and Vaccines in Infectious Diseases
Figure 19. Global RNA-Based Therapeutics and Vaccines Market: Infectious Diseases (2019-2024) & ($ Millions)
Figure 20. RNA-Based Therapeutics and Vaccines in Genetic Diseases
Figure 21. Global RNA-Based Therapeutics and Vaccines Market: Genetic Diseases (2019-2024) & ($ Millions)
Figure 22. RNA-Based Therapeutics and Vaccines in Others
Figure 23. Global RNA-Based Therapeutics and Vaccines Market: Others (2019-2024) & ($ Millions)
Figure 24. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Application in 2023
Figure 25. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Player in 2023
Figure 26. Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Regions (2019-2024)
Figure 27. Americas RNA-Based Therapeutics and Vaccines Market Size 2019-2024 ($ Millions)
Figure 28. APAC RNA-Based Therapeutics and Vaccines Market Size 2019-2024 ($ Millions)
Figure 29. Europe RNA-Based Therapeutics and Vaccines Market Size 2019-2024 ($ Millions)
Figure 30. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size 2019-2024 ($ Millions)
Figure 31. Americas RNA-Based Therapeutics and Vaccines Value Market Share by Country in 2023
Figure 32. United States RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 33. Canada RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 34. Mexico RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 35. Brazil RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 36. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Region in 2023
Figure 37. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Type in 2023
Figure 38. APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Application in 2023
Figure 39. China RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 40. Japan RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 41. Korea RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 42. Southeast Asia RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 43. India RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 44. Australia RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 45. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Country in 2023
Figure 46. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
Figure 47. Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
Figure 48. Germany RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 49. France RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 50. UK RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 51. Italy RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 52. Russia RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 53. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Region (2019-2024)
Figure 54. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2019-2024)
Figure 55. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2019-2024)
Figure 56. Egypt RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 57. South Africa RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 58. Israel RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 59. Turkey RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 60. GCC Country RNA-Based Therapeutics and Vaccines Market Size Growth 2019-2024 ($ Millions)
Figure 61. Americas RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 62. APAC RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 63. Europe RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 64. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 65. United States RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 66. Canada RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 67. Mexico RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 68. Brazil RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 69. China RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 70. Japan RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 71. Korea RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 72. Southeast Asia RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 73. India RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 74. Australia RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 75. Germany RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 76. France RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 77. UK RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 78. Italy RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 79. Russia RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 80. Spain RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 81. Egypt RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 82. South Africa RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 83. Israel RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 84. Turkey RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 85. GCC Countries RNA-Based Therapeutics and Vaccines Market Size 2025-2030 ($ Millions)
Figure 86. Global RNA-Based Therapeutics and Vaccines Market Size Market Share Forecast by Type (2025-2030)
Figure 87. Global RNA-Based Therapeutics and Vaccines Market Size Market Share Forecast by Application (2025-2030)
